Participants in the study had not responded to previous drug treatments.Globes correspondent 5 Jun 08 16:39
Medical device company Brainsway Ltd. (TASE:BRIN) has reported the interim results of the trial of its Deep Transcranial Magnetic Stimulation (TMS) device in the treatment of bio-polar disorder (manic depressive) patients at the Shalvata psychiatric hospital who did not respond to other treatments.
The results showed a satisfactory response among patients who had previously been treated with antidepressants, and who did not report any side effects during the trial. 80% of the patients responded to treatment, with more than 50% reporting a significant improvement, using the various depression measurement scales.
Our fellow weblog Brain Stimulant has an interesting comment on these results.
